Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Rose hip, the fruit of the wild rose (Rosa canina), has been studied for its potential anti-inflammatory and antioxidant properties. There is some emerging scientific evidence suggesting that rose hip extracts may benefit inflammatory conditions, including Inflammatory Bowel Disorders (IBD) such as Crohn's disease and ulcerative colitis. Preclinical studies have demonstrated that rose hip contains polyphenols, vitamin C, and galactolipids, which can modulate inflammatory responses and oxidative stress—mechanisms implicated in the pathogenesis of IBD. A few small clinical studies and animal models have reported that rose hip supplementation may reduce markers of inflammation and improve gut mucosal health. However, the quantity and quality of clinical evidence are limited; most human studies have focused on osteoarthritis or general inflammation rather than specifically on IBD. The evidence to date is promising but not robust, with a lack of large, well-controlled clinical trials directly evaluating rose hip in IBD patients. Thus, while there is scientific rationale and preliminary data supporting its potential use, more research is necessary before rose hip can be recommended as an evidence-based treatment for IBD.

More about Rose Hip
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by Rose Hip

Products containing Rose Hip